Sayenko Kharenko secured Ukrainian merger clearance for Merck with respect to the sale of global Consumer Health business to Procter & Gamble

The Sayenko Kharenko antitrust team has acted as legal advisor to Merck KGaA, a leading science and technology company in healthcare, life science and performance materials, on the sale of its global Consumer Health business to Procter & Gamble for approximately €3.4bn cash, or approximately $ 4.2 billion at applicable exchange rates.

The transaction has been executed through the sale of Merck’s shares in a number of legal entities as well as various asset sales, and comprises the Consumer Health business across 44 countries, including more than 900 products and two Consumer Health-managed production sites located in Spittal an der Drau (Austria) and Goa (India).

The Sayenko Kharenko antitrust team advising on the project included counsel Valentyna Hvozd and associate Anastasia Bodnar, and was led by partner Vladimir Sayenko